Anebulo Pharmaceuticals Inc (ANEB)

Currency in USD
2.500
+0.060(+2.46%)
Closed·
2.5000.000(0.00%)
·
ANEB Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
ANEB is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2.4002.590
52 wk Range
0.8003.420
Key Statistics
Prev. Close
2.44
Open
2.49
Day's Range
2.4-2.59
52 wk Range
0.8-3.42
Volume
84.24K
Average Volume (3m)
385.06K
1-Year Change
26.26%
Book Value / Share
0.33
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ANEB Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
0.000
Downside
-100.00%
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins
Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Anebulo Pharmaceuticals Inc Company Profile

Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing treatments for unintentional cannabis poisoning, acute cannabinoid intoxication, and acute cannabis-induced conditions in the United States. Its lead product candidate is the selonabant, a small molecule antagonist of cannabinoid binding receptor type-1, which is in a phase II clinical trial to address the unmet medical need for a specific antidote for cannabis toxicity. The company was incorporated in 2020 and is based in Lakeway, Texas.

Compare ANEB to Peers and Sector

Metrics to compare
ANEB
Peers
Sector
Relationship
P/E Ratio
−13.4x−0.5x−0.5x
PEG Ratio
−0.450.280.00
Price/Book
7.6x0.9x2.6x
Price / LTM Sales
-1.6x3.3x
Upside (Analyst Target)
20.0%376.2%40.1%
Fair Value Upside
Unlock0.1%5.1%Unlock

Analyst Ratings

0 Buy
2 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 0.000

Earnings

Latest Release
May 13, 2025
EPS / Forecast
-0.04 / -0.08
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

ANEB Income Statement

People Also Watch

2.140
VOR
+8.08%
21.81
SRPT
+7.44%
2.53
INMB
+3.27%
0.772
GAME
-13.26%
70.44
ABVX
+1.27%

FAQ

What Stock Exchange Does Anebulo Pharmaceuticals Trade On?

Anebulo Pharmaceuticals is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Anebulo Pharmaceuticals?

The stock symbol for Anebulo Pharmaceuticals is "ANEB."

What Is the Anebulo Pharmaceuticals Market Cap?

As of today, Anebulo Pharmaceuticals market cap is 102.71M.

What Is Anebulo Pharmaceuticals's Earnings Per Share (TTM)?

The Anebulo Pharmaceuticals EPS (TTM) is -0.26.

When Is the Next Anebulo Pharmaceuticals Earnings Date?

Anebulo Pharmaceuticals will release its next earnings report on 06 Nov 2025.

From a Technical Analysis Perspective, Is ANEB a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Anebulo Pharmaceuticals Stock Split?

Anebulo Pharmaceuticals has split 0 times.

How Many Employees Does Anebulo Pharmaceuticals Have?

Anebulo Pharmaceuticals has 3 employees.

What is the current trading status of Anebulo Pharmaceuticals (ANEB)?

As of 17 Aug 2025, Anebulo Pharmaceuticals (ANEB) is trading at a price of 2.50, with a previous close of 2.44. The stock has fluctuated within a day range of 2.40 to 2.59, while its 52-week range spans from 0.80 to 3.42.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.